within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DD62_CefoperazoneAndBetaLactamaseInhibitor;

model CefoperazoneAndBetaLactamaseInhibitor
  extends Pharmacolibrary.Drugs.ATC.J.J01DD62;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01DD62</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Cefoperazone is a third-generation cephalosporin antibiotic, often combined with beta-lactamase inhibitors (such as sulbactam or tazobactam) to broaden its spectrum against beta-lactamase-producing gram-negative bacteria. This combination is used for the treatment of moderate to severe infections including respiratory tract, urinary tract, intra-abdominal infections, and sepsis. It is approved and used clinically, mainly in hospital settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for typical adult patients based on available data for cefoperazone with sulbactam. No direct PK publication found for the exact combination ATC J01DD62; parameters estimated from available literature on cefoperazone combinations.</p><h4>References</h4><ol><li><p>Johnson, CA, et al., &amp; Craig, WA (1988). Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis. <i>Antimicrobial agents and chemotherapy</i> 32(1) 51–56. DOI:<a href=\"https://doi.org/10.1128/AAC.32.1.51\">10.1128/AAC.32.1.51</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3348613/\">https://pubmed.ncbi.nlm.nih.gov/3348613</a></p></li><li><p>Muder, RR, et al., &amp; Venkataramanan, R (2002). Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients. <i>Journal of clinical pharmacology</i> 42(6) 644–650. DOI:<a href=\"https://doi.org/10.1177/00970002042006006\">10.1177/00970002042006006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12043952/\">https://pubmed.ncbi.nlm.nih.gov/12043952</a></p></li><li><p>Danziger, LH, et al., &amp; Rodvold, KA (1994). Steady-state pharmacokinetics of cefoperazone and sulbactam in patients with acute appendicitis. <i>The Annals of pharmacotherapy</i> 28(6) 703–707. DOI:<a href=\"https://doi.org/10.1177/106002809402800602\">10.1177/106002809402800602</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7919553/\">https://pubmed.ncbi.nlm.nih.gov/7919553</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end CefoperazoneAndBetaLactamaseInhibitor;
